ASTRAZENECA PLC 4

Mani Sharma, SVP at AstraZeneca PLC, acquired small amounts of ordinary shares (21.233 shares total) via dividend reinvestment and a share incentive plan, bringing direct holdings to 19,288.6989 shares.

On this Form 4, AstraZeneca PLC SVP, Group Controller and Head of Global Finance Services Mani Sharma reported two routine equity acquisitions tied to company share plans. On 2026-08-08, the insider acquired 20.233 ordinary shares for approximately $160.57 in total via automatic reinvestment of dividends accrued under the Restricted Share Plan, at an implied U.S. dollar price of about $7.94 per share (corresponding to GBP118.96 converted at $1.3498/GBP). On 2026-09-08, the insider acquired 1 ordinary share for roughly $162.60 pursuant to the Issuer’s Share Incentive Plan, based on a GBP120.26 purchase price converted at $1.3521/GBP. Following these small plan-based acquisitions, the insider’s direct ownership increased marginally from 19,287.6989 to 19,288.6989 ordinary shares, representing a modest change in economic exposure consistent with ongoing compensation and employee share purchase arrangements rather than open‑market trading.

Filing Facts

CIK

901832

Ticker

AZN

Form

4

Source Type

fda

Accession

0001104659-26-107055

Alert Tier

4